CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- 8-K Event Results of operations
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- DEF 14A Proxy Proxy Statement
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- PRER14A Other PRER14A
- UPLOAD Other SEC-generated Letter
- 8-K Event Regulation FD disclosure
- D Other Notice of Sales of Unregistered Securities
- SC 13D/A Stake Beneficial Ownership Report
- S-3 Offering Registration Statement
- SC 13D/A Stake Beneficial Ownership Report
- 4 Grant or award Director acquired 35,381 shares (grant or award)
- 4 Grant or award 10% owner acquired 247,665 shares (grant or award)
- 4 Grant or award Director acquired 247,665 shares (grant or award)
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market buy 10% owner bought 276,801 shares at $2.25 ($622,802)
- 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed · Bylaws or fiscal year change
Page 39 of 45 · 895 filings